{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:39:05Z","timestamp":1792834745834,"version":"4.5.0"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      To investigate the mechanism of Shengmai San (SMS) in the treatment of lung adenocarcinoma (LUAD) based on an integrated strategy combining \u201cnetwork pharmacology, bioinformatics, molecular docking, and molecular dynamics simulation,\u201d aiming to provide a precise combination therapy strategy and identify potential bioactive compounds. Differentially expressed genes in LUAD were identified from the Gene Expression Omnibus database using R (originally developed at Bell Laboratories and currently managed by Lucent Technologies). SMS components (ginseng,\n                      <jats:italic toggle=\"yes\">Ophiopogon japonicus<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">Schisandra chinensis<\/jats:italic>\n                      ) were retrieved from encyclopaedia of traditional Chinese medicine, with Lipinski-compliant compounds selected. Compound targets were predicted via SwissTargetPrediction and Similarity Ensemble Approach. Intersecting targets between differentially expressed genes and compound targets were identified for \u201cherbs-compounds-targets-disease\u201d network construction. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed. Hub targets were identified by analyzing the protein\u2013protein interaction network. High-prognostic relevance targets were screened from The Cancer Genome Atlas. Compounds targeting these were identified through the herbs-compounds-targets-disease network, and absorption, distribution, metabolism, excretion, and toxicity-compliant compounds were selected using SwissADME (a web\u2010based tool provided by the Molecular Modeling Group of the Swiss Institute of Bioinformatics). Core regulatory targets were identified through molecular docking, with complex stability assessed by molecular dynamics simulations. The key bioactive compounds of SMS for treating LUAD were identified as 7-hydroxy-2,5-dimethyl-4\n                      <jats:italic toggle=\"yes\">H<\/jats:italic>\n                      -1-benzopyran-4-one,\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -trans-feruloyltyramine, paprazine, and (E)-\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -[(2\n                      <jats:italic toggle=\"yes\">S<\/jats:italic>\n                      )-2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-(4-hydroxyphenyl)prop-2-enamide. Hub targets included AURKA, CCNA2, CCNB1, CDK1, CHEK1, KIF11, NEK2, PLK1, TTK, and TYMS. Among these, CDK1, CHEK1, and PLK1 demonstrated both high-prognostic relevance and strong binding affinity with SMS, emerging as core regulatory targets for SMS in LUAD treatment. Mechanistically, SMS exerts its anticancer effects primarily by modulating the tumor necrosis factor, interleukin-17, cell cycle, and Lipid and atherosclerosis signaling pathways. The active components of SMS, such as paprazine, may exert antitumor effects partly through downregulating CDK1, CHEK1, and PLK1 expression. Although the present study did not examine drug-resistance models or combination regimens, our findings raise the possibility that, in patients with high expression of these genes, combining SMS with standard chemotherapy or targeted therapy could potentially enhance chemosensitivity and mitigate the development of resistance. This hypothesis, however, requires formal testing in appropriate preclinical models and functional validation studies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050440","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:01:32Z","timestamp":1787968892000},"page":"e50440","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the mechanism of Shengmai San in treating lung adenocarcinoma based on bioinformatics and molecular dynamics simulation"],"prefix":"10.1097","volume":"105","author":[{"given":"Xiaoling","family":"Zhou","sequence":"first","affiliation":[{"name":"School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China"},{"name":"School of Intelligent Medicine and Information Engineering, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-4005","authenticated-orcid":false,"given":"Diyao","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyou","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China"},{"name":"School of Intelligent Medicine and Information Engineering, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261024","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12967-024-04919-z","article-title":"Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.","volume":"22","author":"Zhang","year":"2024","journal-title":"J Transl Med"},{"key":"R2-20261024","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.3390\/ijms241914614","article-title":"Regulation of ferroptosis in lung adenocarcinoma.","volume":"24","author":"Wei","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R3-20261024","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-017-0682-z","article-title":"PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt\/\u03b2-catenin signaling pathway.","volume":"16","author":"Zhan","year":"2017","journal-title":"Mol Cancer"},{"key":"R4-20261024","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s12539-018-0300-9","article-title":"Transcription factors contribute to differential expression in cellular pathways in lung adenocarcinoma and lung squamous cell carcinoma.","volume":"10","author":"Liu","year":"2018","journal-title":"Interdiscip Sci"},{"key":"R5-20261024","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12033-024-01061-5","article-title":"Integrin \u03b24 regulates cell migration of lung adenocarcinoma through FAK signaling.","volume":"67","author":"Zhang","year":"2025","journal-title":"Mol Biotechnol"},{"key":"R6-20261024","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.3390\/ijms25126381","article-title":"The nucleolar protein C1orf131 is a novel gene involved in the progression of lung adenocarcinoma cells through the AKT signalling pathway.","volume":"25","author":"Wei","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R7-20261024","doi-asserted-by":"crossref","first-page":"130706","DOI":"10.1016\/j.bbagen.2024.130706","article-title":"COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma.","volume":"1868","author":"Wu","year":"2024","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"R8-20261024","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.21037\/jtd-22-1522","article-title":"Exploration of the shared genes and signaling pathways between lung adenocarcinoma and idiopathic pulmonary fibrosis.","volume":"15","author":"Li","year":"2023","journal-title":"J Thorac Dis"},{"key":"R9-20261024","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.3390\/ijms19113611","article-title":"The role of TGF-\u03b2 signaling in lung cancer associated with idiopathic pulmonary fibrosis.","volume":"19","author":"Saito","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R10-20261024","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/COC.0000000000001088","article-title":"Advancements in NSCLC: from pathophysiological insights to targeted treatments.","volume":"47","author":"Xu","year":"2024","journal-title":"Am J Clin Oncol"},{"key":"R11-20261024","doi-asserted-by":"crossref","first-page":"1201573","DOI":"10.3389\/fimmu.2023.1201573","article-title":"A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.","volume":"14","author":"Ren","year":"2023","journal-title":"Front Immunol"},{"key":"R13-20261024","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1039\/D2MO00261B","article-title":"Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer.","volume":"19","author":"Wang","year":"2023","journal-title":"Mol Omics"},{"key":"R14-20261024","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1158\/1535-7163.MCT-17-0597","article-title":"Path toward precision oncology: review of targeted therapy studies and tools to aid in defining \u201cactionability\u201d of a molecular lesion and patient management support.","volume":"16","author":"Chae","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"R15-20261024","doi-asserted-by":"crossref","first-page":"3S46","DOI":"10.1016\/S0007-4551(25)00157-2","article-title":"Place adjuvant targeted therapies during localized NSCLC.","volume":"112","author":"Girard","year":"2025","journal-title":"Bull Cancer"},{"key":"R16-20261024","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4251\/wjgo.v13.i5.366","article-title":"Molecular-targeted therapy toward precision medicine for gastrointestinal caner: current progress and challenges.","volume":"13","author":"Matsuoka","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"R17-20261024","doi-asserted-by":"crossref","first-page":"2127018","DOI":"10.1155\/2024\/2127018","article-title":"Effectiveness and safety of shengmai san for viral myocarditis: a systematic review and meta-analysis of randomized controlled trials.","volume":"2024","author":"Zhang","year":"2024","journal-title":"Cardiovasc Ther"},{"key":"R18-20261024","doi-asserted-by":"crossref","first-page":"154433","DOI":"10.1016\/j.phymed.2022.154433","article-title":"Shengmai san-derived compound prescriptions: a review on chemical constituents, pharmacokinetic studies, quality control, and pharmacological properties.","volume":"107","author":"Ouyang","year":"2022","journal-title":"Phytomedicine"},{"key":"R19-20261024","doi-asserted-by":"crossref","first-page":"1208621","DOI":"10.3389\/fphar.2023.1208621","article-title":"The effect of Shengmai injection in patients with coronary heart disease in real world and its personalized medicine research using machine learning techniques.","volume":"14","author":"Ma","year":"2023","journal-title":"Front Pharmacol"},{"key":"R20-20261024","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4161\/cbt.19599","article-title":"Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.","volume":"13","author":"Kim","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"R21-20261024","doi-asserted-by":"crossref","first-page":"2172740","DOI":"10.1155\/2020\/2172740","article-title":"A comprehensive review on schisandrin B and its biological properties.","volume":"2020","author":"Nasser","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R22-20261024","doi-asserted-by":"crossref","first-page":"106537","DOI":"10.1016\/j.bioorg.2023.106537","article-title":"Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis.","volume":"135","author":"Dong","year":"2023","journal-title":"Bioorg Chem"},{"key":"R23-20261024","doi-asserted-by":"crossref","first-page":"1274048","DOI":"10.3389\/fonc.2023.1274048","article-title":"Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers.","volume":"13","author":"Xiong","year":"2023","journal-title":"Front Oncol"},{"key":"R24-20261024","first-page":"2103","article-title":"Effects of Shengmai injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: a meta-analysis.","volume":"26","author":"Duan","year":"2018","journal-title":"Support Care Cancer"},{"key":"R25-20261024","doi-asserted-by":"crossref","first-page":"9243681","DOI":"10.1155\/2020\/9243681","article-title":"Shenmai injection supresses glycolysis and enhances cisplatin cytotoxicity in cisplatin-resistant A549\/DDP Cells via the AKT-mTOR-c-Myc signaling pathway.","volume":"2020","author":"Sun","year":"2020","journal-title":"Biomed Res Int"},{"key":"R26-20261024","doi-asserted-by":"crossref","first-page":"865065","DOI":"10.3389\/fphar.2022.865065","article-title":"Study on the mechanism of astragalus polysaccharide in treating pulmonary fibrosis based on \u201cdrug-target-pathway\u201d network.","volume":"13","author":"Bing","year":"2022","journal-title":"Front Pharmacol"},{"key":"R27-20261024","doi-asserted-by":"crossref","first-page":"15834","DOI":"10.1038\/s41598-018-34160-w","article-title":"Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data.","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"key":"R28-20261024","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets \u2013 update.","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R29-20261024","doi-asserted-by":"crossref","first-page":"e10312","DOI":"10.1371\/journal.pone.0010312","article-title":"Gene expression-based classification of non-small cell lung carcinomas and survival prediction.","volume":"5","author":"Hou","year":"2010","journal-title":"PLoS One"},{"key":"R30-20261024","doi-asserted-by":"crossref","first-page":"17203","DOI":"10.3390\/ijms242417203","article-title":"The construction and validation of a novel ferroptosis-related gene signature in Parkinson\u2019s disease.","volume":"24","author":"Liu","year":"2023","journal-title":"IJMS"},{"key":"R31-20261024","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2147\/DMSO.S507953","article-title":"The Shengmai San exerts therapeutic effects on type 2 diabetes by modulating the PI3K\/AKT\/GSK3B signaling pathway.","volume":"18","author":"Shang","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R32-20261024","doi-asserted-by":"crossref","first-page":"D976","DOI":"10.1093\/nar\/gky987","article-title":"ETCM: an encyclopaedia of traditional Chinese medicine.","volume":"47","author":"Xu","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R33-20261024","doi-asserted-by":"crossref","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","article-title":"PubChem 2025 update.","volume":"53","author":"Kim","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"R34-20261024","doi-asserted-by":"crossref","first-page":"1527008","DOI":"10.3389\/fchem.2025.1527008","article-title":"Computational identification of potential natural terpenoid inhibitors of MDM2 for breast cancer therapy: molecular docking, molecular dynamics simulation, and ADMET analysis.","volume":"13","author":"Azme","year":"2025","journal-title":"Front Chem"},{"key":"R35-20261024","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R36-20261024","doi-asserted-by":"crossref","first-page":"785964","DOI":"10.3389\/fphar.2021.785964","article-title":"Integration of system biology tools to investigate huperzine a as an anti-Alzheimer agent.","volume":"12","author":"Khanal","year":"2021","journal-title":"Front Pharmacol"},{"key":"R37-20261024","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry.","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat Biotechnol"},{"key":"R38-20261024","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the Universal Protein Knowledgebase in 2025.","volume":"53","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"R39-20261024","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R40-20261024","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5114\/ceh.2025.148439","article-title":"Identification of the shared gene signatures and biological mechanism in type 2 diabetes mellitus and hepatocellular carcinoma.","volume":"11","author":"Lin","year":"2025","journal-title":"Clin Exp Hepatol"},{"key":"R41-20261024","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.2174\/0113816128287535240429043610","article-title":"Exploring the molecular mechanisms of huaier on modulating metabolic reprogramming of hepatocellular carcinoma: a study based on network pharmacology, molecular docking and bioinformatics.","volume":"30","author":"Wan","year":"2024","journal-title":"Curr Pharm Des"},{"key":"R42-20261024","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"R43-20261024","doi-asserted-by":"crossref","first-page":"16522","DOI":"10.1038\/s41598-025-99811-1","article-title":"Antioxidant activity, molecular docking, and modeling pharmacokinetics study of some benzo[f]quinoline candidates.","volume":"15","author":"El-Fagal","year":"2025","journal-title":"Sci Rep"},{"key":"R44-20261024","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/ph17040510","article-title":"Unveiling the potential of ent-kaurane diterpenoids: multifaceted natural products for drug discovery.","volume":"17","author":"Kibet","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"R45-20261024","doi-asserted-by":"crossref","first-page":"e0332048","DOI":"10.1371\/journal.pone.0332048","article-title":"Phytochemical profiling and bioactivity validation of Moringa oleifera leaves: antimicrobial, antidiarrheal, analgesic, and in silico insights.","volume":"20","author":"Taher","year":"2025","journal-title":"PLoS One"},{"key":"R46-20261024","doi-asserted-by":"crossref","first-page":"16662","DOI":"10.1038\/s41598-025-00371-1","article-title":"Modeling the functionalized genistein-hyoscyamine derivatives.","volume":"15","author":"Abd-ElSalam","year":"2025","journal-title":"Sci Rep"},{"key":"R47-20261024","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2174\/0115734099258321231003161602","article-title":"Molecular modelling of resveratrol derivatives with SIRT1 for the stimulation of deacetylase activity.","volume":"20","author":"Zamani","year":"2024","journal-title":"Curr Comput Aided Drug Des"},{"key":"R48-20261024","doi-asserted-by":"crossref","first-page":"1580993","DOI":"10.3389\/fgene.2025.1580993","article-title":"Impact of nonsynonymous single nucleotide polymorphisms in PROCR gene on protein stability and thrombotic risk: a molecular dynamic approach.","volume":"16","author":"Abuagla","year":"2025","journal-title":"Front Genet"},{"key":"R49-20261024","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.3390\/ijms241210370","article-title":"Network pharmacology, molecular docking and molecular dynamics to explore the potential immunomodulatory mechanisms of deer antler.","volume":"24","author":"Liu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R50-20261024","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12885-020-6579-z","article-title":"Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.","volume":"20","author":"Ruiz-Cordero","year":"2020","journal-title":"BMC Cancer"},{"key":"R51-20261024","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-20-1835","article-title":"Transcriptional subtypes resolve tumor heterogeneity and identify vulnerabilities to MEK inhibition in lung adenocarcinoma.","volume":"27","author":"Daemen","year":"2021","journal-title":"Clin Cancer Res"},{"key":"R52-20261024","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.3390\/cancers16223818","article-title":"Identification of molecular subtypes and prognostic traits based on chromosomal instability phenotype-related genes in lung adenocarcinoma.","volume":"16","author":"Jeon","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R53-20261024","doi-asserted-by":"crossref","first-page":"652193","DOI":"10.3389\/fonc.2021.652193","article-title":"Integrated analysis of genomic and immunological features in lung adenocarcinoma with micropapillary component.","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"R54-20261024","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/cas.14390","article-title":"Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state.","volume":"111","author":"Huang","year":"2020","journal-title":"Cancer Sci"},{"key":"R55-20261024","doi-asserted-by":"crossref","first-page":"638374","DOI":"10.3389\/fcell.2021.638374","article-title":"Single-cell analysis reveals spatial heterogeneity of immune cells in lung adenocarcinoma.","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R56-20261024","doi-asserted-by":"crossref","first-page":"645482","DOI":"10.3389\/fcell.2021.645482","article-title":"Glycolysis define two prognostic subgroups of lung adenocarcinoma with different mutation characteristics and immune infiltration signatures.","volume":"9","author":"Huo","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R57-20261024","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2174\/0929867331666230818144416","article-title":"Heterogeneity of lipid metabolism and its clinical and immune correlation in lung adenocarcinoma.","volume":"31","author":"Zhang","year":"2024","journal-title":"Curr Med Chem"},{"key":"R58-20261024","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/bjc.2018.3","article-title":"An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.","volume":"118","author":"Linton","year":"2018","journal-title":"Br J Cancer"},{"key":"R59-20261024","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1158\/0008-5472.CAN-20-3580","article-title":"Integrated screens identify CDK1 as a therapeutic target in advanced gastrointestinal stromal tumors.","volume":"81","author":"Lu","year":"2021","journal-title":"Cancer Res"},{"key":"R60-20261024","doi-asserted-by":"crossref","first-page":"e26474","DOI":"10.1097\/MD.0000000000026474","article-title":"Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R61-20261024","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/ijc.33702","article-title":"Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.","volume":"149","author":"Mu","year":"2021","journal-title":"Int J Cancer"},{"key":"R62-20261024","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12943-021-01380-0","article-title":"CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma.","volume":"20","author":"Gu","year":"2021","journal-title":"Mol Cancer"},{"key":"R63-20261024","doi-asserted-by":"crossref","first-page":"e1011309","DOI":"10.1371\/journal.pgen.1011309","article-title":"Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD.","volume":"20","author":"Kong","year":"2024","journal-title":"PLoS Genet"},{"key":"R64-20261024","doi-asserted-by":"crossref","first-page":"e1011017","DOI":"10.1371\/journal.pgen.1011017","article-title":"Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling.","volume":"19","author":"Li","year":"2023","journal-title":"PLoS Genet"},{"key":"R65-20261024","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ardp.201000207","article-title":"In-vitro antiproliferative activity of benzopyranone derivatives in comparison with standard chemotherapeutic drugs.","volume":"344","author":"Musa","year":"2011","journal-title":"Arch Pharm (Weinheim)"},{"key":"R66-20261024","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/or.2016.4804","article-title":"Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition.","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol Rep"},{"key":"R67-20261024","first-page":"968","article-title":"Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K\/Akt pathway in osteosarcoma cell.","volume":"8","author":"Wang","year":"2016","journal-title":"Am J Transl Res"},{"key":"R68-20261024","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.21873\/anticanres.15659","article-title":"N-trans-p-coumaroyltyramine enhances indomethacin- and diclofenac-induced apoptosis through endoplasmic reticulum stress-dependent mechanism in MCF-7 cells.","volume":"42","author":"Wongsakul","year":"2022","journal-title":"Anticancer Res"},{"key":"R69-20261024","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.3390\/molecules26103041","article-title":"Design, synthesis, and antitumor activity of olmutinib derivatives containing acrylamide moiety.","volume":"26","author":"Hu","year":"2021","journal-title":"Molecules"},{"key":"R70-20261024","doi-asserted-by":"crossref","first-page":"33787","DOI":"10.1038\/s41598-025-01232-7","article-title":"Computational identification and evaluation of novel PD-L1 inhibitors for cancer immunotherapy.","volume":"15","author":"Manzoor","year":"2025","journal-title":"Sci Rep"},{"key":"R71-20261024","doi-asserted-by":"crossref","first-page":"33887","DOI":"10.1038\/s41598-025-07975-7","article-title":"Seasonal variation in the phenolic compounds of Algerian Cistus creticus leaf extracts: an in silico and in vitro study.","volume":"15","author":"Aouiffat","year":"2025","journal-title":"Sci Rep"},{"key":"R72-20261024","doi-asserted-by":"crossref","first-page":"106344","DOI":"10.1016\/j.biocel.2022.106344","article-title":"CircSETD3 mediates acquired resistance to gefitinib in non-small lung cancer cells by FXR1\/ECT2 pathway.","volume":"154","author":"Wen","year":"2023","journal-title":"Int J Biochem Cell Biol"},{"key":"R73-20261024","first-page":"37","article-title":"Regulation of oncoprotein 18\/stathmin signaling by ERK concerns the resistance to taxol in nonsmall cell lung cancer cells.","volume":"31","author":"Lin","year":"2016","journal-title":"Cancer Biother Radiopharm"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:01:34Z","timestamp":1792832494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":72,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050440","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2025-01-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}